SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Active filters
Keyword
All time
Results for " neurosense " 2 found π AI-powered Shuffle
Sign in to save shuffle history.
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying...
π
Neutral
(10%)
NeuroSense Provides Business Update and Progress for the First Half of 2026
/PRNewswire/ -- Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing...